OFF-LABEL INDICATIONS

Clinical trials for OFF-LABEL INDICATIONS explained in plain language.

Never miss a new study

Get alerted when new OFF-LABEL INDICATIONS trials appear

Sign up with your email to follow new studies for OFF-LABEL INDICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Last-Resort CAR-T therapy made available for desperate patients

Disease control AVAILABLE

This program provides access to a cancer treatment called tisagenlecleucel (Kymriah) for people with lymphoma, leukemia, or other conditions where standard treatments have failed. It is for patients who cannot join a clinical trial and have no other good options. The goal is to o…

Matched conditions: OFF-LABEL INDICATIONS

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated May 07, 2026 18:39 UTC

OFF-LABEL INDICATIONS

Get alerted when new OFF-LABEL INDICATIONS trials appear

Last-Resort CAR-T therapy made available for desperate patients